These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Percutaneous Ethanol Injection in the treatment of hepatocellular carcinoma in cirrhosis. Livraghi T Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1248-53. PubMed ID: 9730383 [No Abstract] [Full Text] [Related]
48. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C; J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetic imaging of 11C ethanol with PET in eight patients with hepatocellular carcinomas who were scheduled for treatment with percutaneous ethanol injection. Dimitrakopoulou-Strauss A; Strauss LG; Gutzler F; Irngartinger G; Kontaxakis G; Kim DK; Oberdorfer F; van Kaick G Radiology; 1999 Jun; 211(3):681-6. PubMed ID: 10352591 [TBL] [Abstract][Full Text] [Related]
50. Hemobilia following percutaneous ethanol injection for hepatocellular carcinoma in a cirrhotic patient. de Sio I; Castellano L; Calandra M J Clin Ultrasound; 1992; 20(9):621-3. PubMed ID: 1331193 [No Abstract] [Full Text] [Related]